StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): a randomised, double-masked, sham-controlled, clinical trial comparing low-voltage X-ray irradiation and as needed bevacizumab, with as needed bevacizumab monotherapy

Jackson, Timothy (Primary Investigator)
Kelly, Joanna (Co-Investigator)
Murphy, Caroline (Co-Investigator)
Peacock, Janet (Co-Investigator)
Pickles, Andrew (Co-Investigator)
Wang, Yanzhong (Co-Investigator)

Project: Research

Status	Finished
Effective start/end date	1/12/2014 → 31/10/2022

Collaborative partners

King's College London (lead)
KCH King's College Hospital NHS Foundation Trust
Oraya Therapeutics, Inc.
Queen's University Belfast
University of Bristol
University of Oxford

Funding

NIHR National Institute For Health & Care Research: £2,240,170.00